AGMBAgomAb Therapeutics NV
$9.11
$9.11
$8.5652 weeks$17.57
AGMB in its own filings
Nothing in AGMB's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
11
Events found in the filings · across 46 filings · the record starts in 2026
- Hard flags
- none
Hard flags
- Most recent filing
- Oct 1, 2026
Most recent filing · Form 6-K
- Record starts
- Feb 9, 2026
Record starts · the earliest filing Ryufin holds for this name
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
opening the record…
Biotechnology
The closest names by size in the same industry